Acidobacteriota
An overview of the phylum Acidobacteriota
Acidobacteriota is a phylum of bacteria that is widely distributed in the environment, particularly in soil ecosystems. Members of this phylum are known for their ability to thrive in acidic conditions, although they can also be found in neutral and alkaline environments.
Characteristics
Acidobacteriota are Gram-negative bacteria that exhibit a wide range of metabolic capabilities. They are known for their ability to degrade complex organic compounds, which makes them important players in the carbon cycle. These bacteria are often difficult to culture in laboratory settings, which has historically limited our understanding of their diversity and ecological roles.
Ecology
Acidobacteriota are ubiquitous in soil environments and are often one of the most abundant bacterial groups in soil microbial communities. They play a crucial role in soil health and nutrient cycling. Their ability to degrade complex polysaccharides and other organic materials contributes to the breakdown of organic matter and the release of nutrients that are essential for plant growth.
Taxonomy
The phylum Acidobacteriota is divided into several classes, orders, and families. The taxonomy of this group is still under active research, with new species and genera being described as more advanced molecular techniques are applied to study their diversity.
Significance
The ecological significance of Acidobacteriota lies in their contribution to soil fertility and their potential use in bioremediation. Their ability to survive in a wide range of pH conditions and to degrade recalcitrant organic compounds makes them valuable for environmental applications.
Research
Recent advances in metagenomics and metatranscriptomics have provided new insights into the diversity and function of Acidobacteriota. These techniques allow researchers to study these bacteria in their natural environments without the need for cultivation, revealing their roles in various biogeochemical processes.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD